Clinics in Dermatology
Volume 28, Issue 1 , Pages 2-7 , January 2010

The role of Propionibacterium acnes in acne pathogenesis: facts and controversies

References 

  1. Harper JC, Thiboutot DM. Pathogenesis of acne: research advances. Adv Dermatol. 2003;19:1–10
  2. Unna P. The histopathology of disease of the skin. New York: Macmillan and Co; 1896;
  3. Fleming A. On the etiology of acne vulgaris and its treatment by vaccines. Lancet. 1909;1:1035–1038
  4. Strauss JS, Kligman AM. The pathologic dynamics of acne vulgaris. Arch Dermatol. 1960;82:779–791
  5. Evans CA, Smith WM, Johnston EA, et al. Bacterial flora of the normal human skin. J Invest Dermatol. 1950;15:305–324
  6. Leyden JL, McGinley KJ, Mills OH, et al. Propionibacterium levels in patients with and without acne vulgaris. J Invest Dermatol. 1975;65:382–384
  7. Leeming JP, Holland KT, Cunliffe WJ. The microbial colonization of inflamed acne vulgaris lesions. Br J Dermatol. 1988;118:203–208
  8. Holland KT, Cunliffe WJ, Rorberts CD. The role of bacteria in acne vulgaris–a new approach. Clin Exp Dermatol. 1978;3:253–257
  9. Ross JI, Snelling AM, Carnegie E, et al. Antibiotic-resistant acne: lessons from Europe. Br J Dermatol. 2003;148:467–478
  10. Eady EA, Jones CE, Tipper JL, et al. Antibiotic resistant propionibacteria in acne: Need for policies to modify antibiotic usage. Br Med J. 1993;306:555–556
  11. Vowels BR, Yang S, Leyden JJ. Induction of proinflammatory cytokines by a soluble factor of Propionibacterium acnes: Implications for chronic inflammation in acne. Infect Immun. 1995;63:3158–3165
  12. Jeremy AH, Holland DB, Roberts SG, et al. Inflammatory events are involved in acne lesion initiation. J Invest Dermatol. 2003;121:20–27
  13. Kim J, Ochoa MT, Krutzik SR, et al. Activation of toll-like receptor 2 in acne triggers inflammatory cytokine response. J Immunol. 2002;169:1535–1541
  14. Jugeau S, Tenaud I, Knol AC, et al. Induction of toll-like receptors by Propionibacterium acnes. Br J Dermatol. 2005;153:1105–1113
  15. Jarrousse V, Castex-Rizzi N, Khammari A, et al. Modulation of integrins and filaggrin expression by Priopionibacterium acnes extracts on keratinocytes. Arch Dermatol Res. 2007;299:441–447
  16. Nagy I, Pivarcsi A, Koreck A, Széll M, Urbán E, Kemény L. Distinct strains of Propionibacterium acnes induce selective human beta-defensin-2 and interleukin-8 expression in human keratinocytes through toll-like receptors. J Invest Dermatol. 2005;124:931–938
  17. Graham GM, Farrar MD, Cruse-Sawyer JE, Holland KT, Ingham E. Proinflammatory cytokine production by human keratinocytes stimulated with Propionibacterium acnes and P acnes GroEL. Br J Dermatol. 2004;150:421–428
  18. Guy R, Green MR, Kealey T. Modeling acne in vitro. J Invest Dermatol. 1996;106:176–182
  19. Burkhart CG, Burkhart CN. Expanding the microcomedone theory and acne therapeutics: Propionibacterium acnes biofilm produces biological glue that holds corneocytes together to form plug. J Am Acad Dermatol. 2007;57:722–724
  20. Burkhart CG, Bukhart CN, Lehmann PL. Acne: a review of immunologic and microbiologic factors. Postgrad Med J. 1999;75:328–331
  21. Hoeffler U. Enzymic and hemolytic properties of Propionibacterium acnes and related bacteria. J Clin Microbiol. 1977;6:555–558
  22. Höffler U, Gehse M, Gloor M, Pulverer G. Enzyme production of propionibacterium from patients with acne vulgaris and healthy persons. Acta Derm Venereol. 1985;65:428–457
  23. Ingham E, Holland KT, Gowland G, et al. Purification and partial characteristics of an acid phosphatase (EC 3.1.3.2) produced by Propionibacterium acnes. J Gen Microbiol. 1980;118:59–65
  24. Marples RR, Downing TD, Kligman AM. Control of free fatty acids in human surface lipids by Corynebacterium acnes. J Invest Deramtol. 1971;56:127–131
  25. Puhvel SM, Reisner RM. The production of hyaluronidase (hyaluronate lyase) by Corynebacterium acnes. J Invest Dermatol. 1972;58:66–70
  26. Webster GF, Leyden JJ, Nilsson UR. Complement activation in acne vulgaris: consumption of complement by comedones. Infect Immun. 1979;26:183–186
  27. Scott DG, Cunliffe WJ, Gowland G. Activation of complement-a mechanism for the inflammation in acne. Br J Dermatol. 1979;101:315–320
  28. Puhvel SM, Sakamoto M. Cytotaxin production of comedonal bacteria (Propionibacterium acnes, P. granulosum, and Staphylococcus epidermidis). J Invest Dermatol. 1980;74:36–39
  29. Webster GF, Leyden JJ. Characterization of serum-independent polymorphonuclear leukocyte chemotactic factors produced by Propionibacterium acnes. Inflammation. 1980;4:261–269
  30. Norris JFB, Cunliffe WJ. A histological and immunocytochemical study of early acne lesions. Br J Dermatol. 1988;118:651–659
  31. Heymann WR. Toll-like receptors in acne vulgaris. J Am Acad Dermatol. 2006;55:691–692
  32. Takeda K, Kaisho T, Akira S. Toll-like receptors. Annu Rev Immunol. 2003;21:335–376
  33. Pivarcsi A, Bodai L, Rethi B, et al. Expression and function of Toll-like receptors 2 and 4 in human keratinocytes. Int Immunology. 2003;15:721–730
  34. Schaller M, Loewenstein M, Borelli C, et al. Induction of a chemoattractive proinflammatory cytokine response after stimulation of keratinocytes with Propionibacterium acnes and coproporphyrin III. Br J Dermatol. 2005;153:66–71
  35. Farrar MD, Ingham E, Holland KT. Heat shock proteins and inflammatory acne vulgaris: molecular cloning, overexpression and purification of a Propionibacterium acnes GroEL and DnaK homologue. FEMS Microbiol Lett. 2000;191:183–186
  36. Whale GA, Sutcliffe IC, Morrisson AR, et al. Purification and characterization of lipoglycan macroamphiphiles from Propionibacterium acnes. Antonie Van Leeuwenhoek. 2004;86:77–85
  37. Katsambas A, Dessinioti C. New and emerging treatments in dermatology: acne. Dermatol Ther. 2008;21:86–95
  38. Liu PT, Krutzik SR, Kim J, Modlin RL. Cutting edge: all trans-retinoic acid down-regulates TLR2 expression and function. J Immunol. 2005;174:2467–2470
  39. Jarrousse V, Castex-Rizzi N, Khammari A, et al. Zinc salts inhibit in vitro Toll-like receptor 2 surface expression by keratinocytes. Eur J Dermatol. 2007;17:492–496
  40. Caux C, Dezutter-Dambuyant C, Schmitt D, Banchereau J. GM-CSF and TNF-alpha cooperate in the generation of dendritic Langerhans cells. Nature. 1992;360:258–261
  41. Kaplan G, Walsh G, Guido LS, et al. Novel responses of human skin to intradermal recombinant granulocyte/macrophage colony-stimulating factor: Langerhans cell recruitment, keratinocyte growth, and enhanced wound healing. J Exp Med. 1992;175:1717–1728
  42. Kimber I, Cumberbatch M, Dearman RJ, et al. Cytokines and chemokines in the initiation and regulation of epidermal Langerhans cell mobilization. Br J Dermatol. 2000;142:401–412
  43. Hoeffler U, Ko HL, Pulverer G. Antimicrobial susceptibility of Propionibacterium acnes and related microbial species. Antimicrob Agents Chemother. 1976;10:387
  44. Webster GF, Leyden JJ, Tsai CC, Baehni P, McArthur WP. Polymorphonuclear leukocyte lysosomal release in response to Propionibacterium acnes in vitro and its enhancement by sera from inflammatory acne patients. J Invest Dermatol. 1980;74:398–401
  45. Antilla HS, Reitamo S, Saurat JH. Interleukin 1 immunoreactivity in sebaceous glands. Br J Dermatol. 1992;127:585–588
  46. Boehm KD, Yun JK, Strohl KP, et al. Messenger RNAs for the multifunctional cytokines interleukin-1 alpha, interleukin-1 beta and tumor necrosis factor-alpha are present in adnexal tissues and in dermis of normal human skin. Exp Dermatol. 1995;4:335–341
  47. Kahari VM, Saariahlo-Kere U. Matrix metalloproteinases in skin. Exp Dermatol. 1997;6:199–213
  48. Papakonstantinou E, Aletras AJ, Glass E, et al. Matrix metalloproteinases of epithelial origin in facial sebum of patients with acne and their regulation by isotretinoin. J Invest Dermatol. 2005;125:673–684
  49. Orentreich N, Durr NP. The natural evolution of comedones into inflammatory papules and pustules. J Invest Dermatol. 1974;62:316–320
  50. Cunliffe WJ, Holland DB, Clark SM, et al. Comedogenesis: some new aetiological, clinical and therapeutic strategies. Br J Dermatol. 2000;142:1084–1091
  51. Plewig G, Fulton JE, Kligman AM. Cellular dynamics of comedo formation in acne vulgaris. Arch Dermatol Forsch. 1971;242:12–29
  52. Knaggs HE, Holland DB, Morris C, Wood EJ, Cunliffe WJ. Quantification of cellular proliferation in acne using the monoclonal antibody Ki67. J Invest Dermatol. 1994;102:89–92
  53. Puhvel SM, Amerian D, Weintraub J, et al. Lymphocytic transformation in subjects with nodulo-cystic acne. Br J Dermatol. 1977;97:205–211
  54. Watt FM. Role of integrins in regulating epidermal adhesion, growth and differentiation. EMBO J. 2002;21:3919–3936
  55. Leyden JJ, McGinley KJ, Vowels B. Propionibacterium acnes colonization in acne and nonacne. Dermatology. 1998;196:55–58
  56. Ingham E, Eady EA, Goodwin CE, et al. Pro-inflammatory levels of interleukin-1 alpha-like bioactivity are present in the majority of open comedones in acne vulgaris. J Invest Dermatol. 1992;98:895–901
  57. Guy R, Kealey T. The effects of inflammatory cytokines on the isolated human sebaceous infundibulum. J Invest Dermatol. 1998;110:410–415
  58. Aldana OL, Holland DB, Cunliffe WJ. A role for interleukin-1α in comedogenesis [abstract]. J Invest Dermatol. 1998;110:558
  59. Kligman AM. An overview of acne. J Invest Dermatol. 1974;62:268–287
  60. Layton AM, Moris C, Cunliffe WJ, et al. Immunohistochemical investigation of evolving inflammation in lesions of acne vulgaris. Exp Dermatol. 1998;7:191–197
  61. Leeming JP, Holland KT, Cunliffe WJ. The pathological and ecological significance of microorganisms colonizing acne vulgaris comedones. J Med Microbiol. 1985;20:11–16

PII: S0738-081X(09)00058-3

doi: 10.1016/j.clindermatol.2009.03.012

Clinics in Dermatology
Volume 28, Issue 1 , Pages 2-7 , January 2010

Article Tools